Risk factors and outcome of bacterial infections in cirrhosis

被引:121
作者
Bruns, Tony [1 ,2 ]
Zimmermann, Henning W. [3 ]
Stallmach, Andreas [1 ,2 ]
机构
[1] Univ Jena, Jena Univ Hosp, Dept Internal Med 4, D-07740 Jena, Germany
[2] Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care, Integrated Res & Treatment Ctr, D-07740 Jena, Germany
[3] Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany
关键词
Immunity; Infection; Cirrhosis; Chronic liver disease; Bacterial translocation; Risk factors; Mortality; NECROSIS-FACTOR-ALPHA; SYSTEMIC INFLAMMATORY RESPONSE; MESENTERIC LYMPH-NODES; GUT EPITHELIAL-CELLS; ACUTE-PHASE PROTEINS; STAGE LIVER-DISEASE; SHORT-TERM SURVIVAL; ACUTE KIDNEY INJURY; ANTIBIOTIC-PROPHYLAXIS; ESCHERICHIA-COLI;
D O I
10.3748/wjg.v20.i10.2542
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Viable and non-viable pathological bacterial translocation promote a self-perpetuating circle of dysfunctional immune activation and systemic inflammation facilitating infections and organ failure in advanced cirrhosis. Bacterial infections and sepsis are now recognized as a distinct stage in the natural progression of chronic liver disease as they accelerate organ failure and contribute to the high mortality observed in decompensated cirrhosis. The increasing knowledge of structural, immunological and hemodynamic pathophysiology in advanced cirrhosis has not yet translated into significantly improved outcomes of bacterial infections over the last decades. Therefore, early identification of patients at the highest risk for developing infections and infection-related complications is required to tailor the currently available measures of surveillance, prophylaxis and therapy to the patients in need in order to improve the detrimental outcome of bacterial infections in cirrhosis. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:2542 / 2554
页数:13
相关论文
共 155 条
[1]
Abdel-Khalek Ehab E, 2011, Arab J Gastroenterol, V12, P173, DOI 10.1016/j.ajg.2011.11.006
[2]
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial [J].
Akriviadis, E ;
Botla, R ;
Briggs, W ;
Han, S ;
Reynolds, T ;
Shakil, O .
GASTROENTEROLOGY, 2000, 119 (06) :1637-1648
[3]
Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis:: amelioration with norfloxacin [J].
Albillos, A ;
de la Hera, A ;
Reyes, E ;
Monserrat, J ;
Muñoz, L ;
Nieto, M ;
Prieto, A ;
Sanz, E ;
Alvarez-Mon, M .
JOURNAL OF HEPATOLOGY, 2004, 40 (04) :624-631
[4]
Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Variants Are Genetic Risk Factors for Death and Spontaneous Bacterial Peritonitis in Liver Cirrhosis [J].
Appenrodt, Beate ;
Gruenhage, Frank ;
Gentemann, Martin G. ;
Thyssen, Lydia ;
Sauerbruch, Tilman ;
Lammert, Frank .
HEPATOLOGY, 2010, 51 (04) :1327-1333
[5]
Antimicrobial Therapeutic Determinants of Outcomes From Septic Shock Among Patients With Cirrhosis [J].
Arabi, Yaseen M. ;
Dara, Saqib I. ;
Memish, Ziad ;
Al Abdulkareem, Abdulmajeed ;
Tamim, Hani M. ;
Al-Shirawi, Nehad ;
Parrillo, Joseph E. ;
Dodek, Peter ;
Lapinsky, Stephen ;
Feinstein, Daniel ;
Wood, Gordon ;
Dial, Sandra ;
Zanotti, Sergio ;
Kumar, Anand .
HEPATOLOGY, 2012, 56 (06) :2305-2315
[6]
Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis [J].
Ariza, Xavier ;
Castellote, Jose ;
Lora-Tamayo, Jaime ;
Girbau, Anna ;
Salord, Silvia ;
Rota, Rosa ;
Ariza, Javier ;
Xiol, Xavier .
JOURNAL OF HEPATOLOGY, 2012, 56 (04) :825-832
[7]
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis [J].
Arvaniti, Vasiliki ;
D'Amico, Gennaro ;
Fede, Giuseppe ;
Manousou, Pinelopi ;
Tsochatzis, Emmanuel ;
Pleguezuelo, Maria ;
Burroughs, Andrew Kenneth .
GASTROENTEROLOGY, 2010, 139 (04) :1246-+
[8]
Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience [J].
Bajaj, Jasmohan S. ;
O'Leary, Jacqueline G. ;
Reddy, K. Rajender ;
Wong, Florence ;
Olson, Jody C. ;
Subramanian, Ram M. ;
Brown, Geri ;
Noble, Nicole A. ;
Thacker, Leroy R. ;
Kamath, Patrick S. .
HEPATOLOGY, 2012, 56 (06) :2328-2335
[9]
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation [J].
Bajaj, Jasmohan S. ;
Hylemon, Phillip B. ;
Ridlon, Jason M. ;
Heuman, Douglas M. ;
Daita, Kalyani ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06) :G675-G685
[10]
Linkage of gut microbiome with cognition in hepatic encephalopathy [J].
Bajaj, Jasmohan S. ;
Ridlon, Jason M. ;
Hylemon, Phillip B. ;
Thacker, Leroy R. ;
Heuman, Douglas M. ;
Smith, Sean ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 302 (01) :G168-G175